Continuous Glucose Monitoring by Insulin-Treated Pilots Flying Commercial Aircraft Within the ARA.MED.330 Diabetes Protocol: A Preliminary Feasibility Study
Authors:
- Gillian Leigh GardenGGGillian Leigh Garden
- Fariba Shojaee-MoradieFSFariba Shojaee-Moradie
- Ewan J. HutchisonEHEwan J. Hutchison
- Brian Murray FrierBFBrian Murray Frier
- Kenneth M. ShawKSKenneth M. Shaw
- Simon R. HellerSHSimon R. Heller
- Gerd KoehlerGKGerd Koehler
- Julia K. MaderJMJulia K. Mader
- Declan MaherDMDeclan Maher
- Graham A. RobertsGRGraham A. Roberts
- David L. Russell-JonesDRDavid L. Russell-Jones
- 31 July 2023
- journal article
- research article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 25 (8) , 543-548
Abstract
Background and Aims: A preliminary study compared the use of continuous glucose monitoring (CGM) with the use of self-monitored blood glucose (SMBG) by aircraft pilots with insulin-treated diabetes in the United Kingdom, Ireland, and Austria, certified to fly commercial aircraft within the European Aviation Safety Agency ARA.MED.330 protocol. Methods: SMBG and simultaneous interstitial glucose measurements using CGM (Dexcom G6 ® ) were recorded during pre- and in-flight periods. Results: Eight male pilots (seven with type 1 diabetes and one with type 3c diabetes), median age of 48.5 years and median diabetes duration of 11.5 years, participated. The correlation coefficient ( R ) between 874 contemporaneously recorded SMBG and CGM values was 0.843, P < 0.001. The mean glucose concentration was 8.78 mmol/L (standard deviation [SD] 0.67) using SMBG compared with 8.71 mmol/L (SD 0.85) recorded using CGM. The mean absolute relative difference was 9.39% (SD 3.12). Conclusions: CGM using Dexcom G6 systems is a credible alternative to SMBG for monitoring glucose levels when insulin-treated pilots fly commercial aircraft. The study was registered with Clinical Trials.gov NCT04395378.Keywords
This publication has 32 references indexed in Scilit:
- Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin InjectionsAnnals of Internal Medicine, 2017
- Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin InjectionsJAMA, 2017
- Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR StudyDiabetes Technology & Therapeutics, 2016
- Assessing Sensor Accuracy for Non-Adjunct Use of Continuous Glucose MonitoringDiabetes Technology & Therapeutics, 2015
- Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetesDiabetology & Metabolic Syndrome, 2013
- The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trialDiabetologia, 2012
- Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin RegimensDiabetes Care, 2012
- Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient dataBMJ, 2011
- Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 DiabetesDiabetes Care, 2011
- Continuous Glucose Monitoring and Intensive Treatment of Type 1 DiabetesNew England Journal of Medicine, 2008